MedTrace Logo

Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control

NCT06067399 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-08-15

No results posted yet for this study

Summary

Diabetes mellitus (DM) is an epidemic disease, with approximately 463 million persons diagnosed with it. Of those, 90% are patients with type 2 DM (T2DM). Some estimates indicate that 700 million cases of DM will be reported in 2045. T2DM develops due to insulin resistance, leading to reduced insulin secretion. DM has a number of associated complications, such as nephropathy, neuropathy, and cardiovascular disease.

Conditions

Interventions

DIAGNOSTIC_TEST

Glycated hemoglobin (HbA1C)

Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )

DIAGNOSTIC_TEST

RDW

Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )

DIAGNOSTIC_TEST

Lipid profile

Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )

Sponsors & Collaborators

  • New Valley University

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2025-12-30
Completion
2026-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06067399 on ClinicalTrials.gov